TREVI THERAPEUTICS

$TRVI
Smart money positioned

13 of the Top-200 alpha managers hold $TRVI as of the latest 13F snapshot.

13F holders
187
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

13 holders · Q1 2026

$TRVI is held by 13 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 0.78%, with an average of 0.24% of portfolio. Largest holder: Soleus Capital Management, L.P. at 0.78%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 187 · Source: 13F-HR
01
Gotham Asset Management, LLC
8.97% of portfolio
13,222,228 sh
02
Heritage Investment Group, Inc.
3.06% of portfolio
9,939,547 sh
03
Mint Tower Capital Management B.V.
5.07% of portfolio
5,094,668 sh
04
Vivo Capital, LLC
5.05% of portfolio
5,094,668 sh
05
Minneapolis Portfolio Management Group, LLC
0.05% of portfolio
3,966,019 sh
06
SevenBridge Financial Group, LLC
0.47% of portfolio
3,712,373 sh
07
Riposte Capital LLC
3.04% of portfolio
3,298,430 sh
08
Staley Capital Advisers Inc.
0.01% of portfolio
2,845,472 sh
09
Axa S.a.
2,665,313 sh
10
Cheviot Value Management, LLC
0.52% of portfolio
2,622,306 sh
See all 187 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $TRVI in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $TRVI in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 07:38 UTC.